Danaher Corporation $DHR Shares Sold by Alyeska Investment Group L.P.

Key Points

• Alyeska Investment Group cut its Danaher position by 62.5% in the second quarter, selling 515,684 shares and retaining 310,000 shares worth approximately $59 million. Institutional investors collectively own 79.05% of Danaher’s outstanding stock.
• Danaher reported quarterly earnings of $1.94 per share, exceeding the $1.85 consensus estimate, while revenue of $6.26 billion also topped expectations and increased 5.5% year over year.
• Analysts maintain a generally positive outlook, with Danaher carrying a “Moderate Buy” consensus rating and an average price target of $228.91, compared with its reported share price of $216.41.

Alyeska Investment Group L.P. lessened its position in Danaher Corporation (NYSE:DHR - Free Report) by 62.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 310,000 shares of the conglomerate's stock after selling 515,684 shares during the period. Alyeska Investment Group L.P.'s holdings in Danaher were worth $59,049,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Main Street Group LTD bought a new position in shares of Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher in the second quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter valued at $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the 4th quarter worth $27,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Trading Up 0.2%

Shares of NYSE DHR opened at $216.41 on Monday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The business has a 50-day moving average price of $199.46 and a two-hundred day moving average price of $192.35. The firm has a market capitalization of $152.13 billion, a PE ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the company earned $0.77 EPS. The firm's quarterly revenue was up 5.5% on a year-over-year basis. As a group, analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on DHR shares. Wells Fargo & Company reduced their target price on Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a report on Wednesday, July 22nd. Royal Bank Of Canada lifted their price target on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Finally, TD Cowen dropped their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source